Kilitch Drugs (India) Limited

NSE:KILITCH.NS

369.3 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 1,543.7251,395.991,142.342685.231533.2824.899510.118286.525209.854190.273148.98331.8081,079.6351,463.0171,426.6241,290.1231,171.766323.838
Cost of Revenue 923.248747.59654.334373.072290.855481.681259.977128.138100.85870.16170.905277.442718.5291,144.3581,104.767994.022892.567248.33
Gross Profit 620.477648.4488.008312.159242.345343.218250.141158.387108.996120.11278.07554.366361.106318.659321.857296.101279.19975.508
Gross Profit Ratio 0.4020.4640.4270.4560.4550.4160.490.5530.5190.6310.5240.1640.3340.2180.2260.230.2380.233
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 019.90112.32720.14715.15314.3029.2151.5425.98701.3620.517044.76644.10481.06268.426.256
Selling & Marketing Expenses 06.5956.1666.82811.88710.8644.2417.0099.14503.9591.866000000
SG&A 412.42726.49618.49326.97527.0425.16613.45518.55115.132129.1175.3212.383044.76644.10481.06268.426.256
Other Expenses 44.78929.182.621.7991.6710.8014.707250.917222.387156.232123.16697.138283.58106.96996.92887.96983.56135.879
Operating Expenses 412.427508.248398.746274.647257.215242.947184.824269.468237.519156.232128.48799.521283.58151.735141.032169.031151.96162.135
Operating Income 208.05148.596100.15641.341-8.43868.69999.26-114.14-116.287-9.48310.63132.756973.626166.924180.825127.07127.23813.373
Operating Income Ratio 0.1350.1060.0880.06-0.0160.0830.195-0.398-0.554-0.050.0710.0990.9020.1140.1270.0980.1090.041
Total Other Income Expenses Net -14.505-28.453-4.0139.85524.51117.167-38.133-3.05912.23626.63661.04277.913896.101-35.762-45.349000.001
Income Before Tax 193.545120.14396.14451.19616.07385.86661.127-114.14-116.287-9.48410.6332.758973.627131.162135.476127.07127.23813.374
Income Before Tax Ratio 0.1250.0860.0840.0750.030.1040.12-0.398-0.554-0.050.0710.0990.9020.090.0950.0980.1090.041
Income Tax Expense 57.79337.31634.00713.537.65347.5689.603-5.634-4.378-6.59-1.135-0.071210.51826.28233.16115.63514.0323.322
Net Income 146.014104.48173.67236.7118.4238.29851.524-108.507-111.909-2.89411.76532.828763.109104.88102.316111.435113.20610.052
Net Income Ratio 0.0950.0750.0640.0540.0160.0460.101-0.379-0.533-0.0150.0790.0990.7070.0720.0720.0860.0970.031
EPS 9.176.714.732.370.552.613.66-8.2-8.46-0.220.892.486.747.927.748.448.521.62
EPS Diluted 9.176.714.732.370.552.613.66-8.2-8.46-0.220.892.446.747.747.588.448.521.62
EBITDA 241.546204.838120.89869.95325.028125.3899.687-13.675-23.857-24.122-12.25648.831131.859222.798241.551188.4190.01440.275
EBITDA Ratio 0.1560.1470.1060.1020.0470.1520.195-0.048-0.114-0.127-0.0820.1470.1220.1520.1690.1460.1620.124